메뉴 건너뛰기




Volumn 3, Issue 5, 2007, Pages 579-585

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension

Author keywords

Amlodipine besylate; Hypertension; Joint National Committee (JNC) 6 and 7; Lisinopril; Valsartan

Indexed keywords

AMLODIPINE BESYLATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LISINOPRIL; VALSARTAN;

EID: 36148938672     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (13)

References (26)
  • 1
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • ALLHAT Collaborative Research Group
    • ALLHAT Collaborative Research Group. 2002. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA, 288:2981-97.
    • (2002) JAMA , vol.288 , pp. 2981-2997
  • 2
    • 23944472238 scopus 로고    scopus 로고
    • Treatment of hypertension in adults with diabetes
    • American Diabetes Association
    • American Diabetes Association. 2002. Treatment of hypertension in adults with diabetes. Diabetes Care, 25:199-201.
    • (2002) Diabetes Care , vol.25 , pp. 199-201
  • 3
    • 0035842331 scopus 로고    scopus 로고
    • A practical approach to achieving recommended blood pressure goals in diabetic patients
    • Bakris GL. 2001. A practical approach to achieving recommended blood pressure goals in diabetic patients. Arch Intern Med, 161:2661-7.
    • (2001) Arch Intern Med , vol.161 , pp. 2661-2667
    • Bakris, G.L.1
  • 4
    • 0037720962 scopus 로고    scopus 로고
    • A comparison of observational studies and randomized, controlled trials
    • Benson & Hartz AJ. 2000. A comparison of observational studies and randomized, controlled trials. Am J Ophthalmol, 130:688.
    • (2000) Am J Ophthalmol , vol.130 , pp. 688
    • Benson1    Hartz, A.J.2
  • 5
    • 4143125777 scopus 로고    scopus 로고
    • Incremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimens
    • Bisognano J, McLaughlin T, Roberts CS, et al. 2004. Incremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimens. Am J Hypertens, 17:676-83.
    • (2004) Am J Hypertens , vol.17 , pp. 676-683
    • Bisognano, J.1    McLaughlin, T.2    Roberts, C.S.3
  • 6
    • 0037851836 scopus 로고    scopus 로고
    • Principal results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial
    • Black HR, Elliott WJ, Grandits G, et al. 2003. Principal results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial. JAMA, 289:2073-82.
    • (2003) JAMA , vol.289 , pp. 2073-2082
    • Black, H.R.1    Elliott, W.J.2    Grandits, G.3
  • 7
    • 0035144723 scopus 로고    scopus 로고
    • Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions
    • Burnier M, Schneider MP, Chiolero A, et al. 2001. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens, 19:335-41.
    • (2001) J Hypertens , vol.19 , pp. 335-341
    • Burnier, M.1    Schneider, M.P.2    Chiolero, A.3
  • 8
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • Charlson ME, Pompei P, Ales KL, et al. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 40:373-83.
    • (1987) J Chronic Dis , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3
  • 9
    • 0347423198 scopus 로고    scopus 로고
    • Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • Chobanian AV, Bakris GL, Black HR, et al. 2003. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42:1206-52.
    • (2003) Hypertension , vol.42 , pp. 1206-1252
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3
  • 10
    • 0034702175 scopus 로고    scopus 로고
    • Randomized, controlled trials, observational studies, and the hierarchy of research designs
    • Concato J, Shah N, Horwitz RI. 2000. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med, 342:1887-92.
    • (2000) N Engl J Med , vol.342 , pp. 1887-1892
    • Concato, J.1    Shah, N.2    Horwitz, R.I.3
  • 11
    • 3543135271 scopus 로고    scopus 로고
    • Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
    • D'Agostino RB Jr. 1998. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med, 17:2265-81.
    • (1998) Stat Med , vol.17 , pp. 2265-2281
    • D'Agostino Jr., R.B.1
  • 12
    • 0037160968 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
    • Dahlöf B, Devereux RB, Kjeldsen SE, et al. 2002. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet, 359:995-1003.
    • (2002) Lancet , vol.359 , pp. 995-1003
    • Dahlöf, B.1    Devereux, R.B.2    Kjeldsen, S.E.3
  • 13
    • 24644443331 scopus 로고    scopus 로고
    • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial
    • Dahlöf B, Sever PS, Poulter NR, et al. 2005. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet, 366:895-906.
    • (2005) Lancet , vol.366 , pp. 895-906
    • Dahlöf, B.1    Sever, P.S.2    Poulter, N.R.3
  • 14
    • 0037527647 scopus 로고    scopus 로고
    • European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension
    • Guidelines Committee
    • Guidelines Committee. 2003. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 21:1011-53.
    • (2003) J Hypertens , vol.21 , pp. 1011-1053
  • 15
    • 0038690424 scopus 로고    scopus 로고
    • Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000
    • Hajjar I, Kotchen TA. 2003. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA, 290:199-206.
    • (2003) JAMA , vol.290 , pp. 199-206
    • Hajjar, I.1    Kotchen, T.A.2
  • 16
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group
    • Hansson L, Zanchetti A, Carruthers SG, et al. 1998. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet, 351:1755-62.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3
  • 17
    • 0034181905 scopus 로고    scopus 로고
    • Clinical Advisory Statement. Importance of systolic blood pressure in older Americans
    • Izzo JL Jr, Levy D, Black HR. 2000. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension, 35:1021-4.
    • (2000) Hypertension , vol.35 , pp. 1021-1024
    • Izzo Jr, J.L.1    Levy, D.2    Black, H.R.3
  • 18
    • 0030713021 scopus 로고    scopus 로고
    • Joint National Committee on, Detection, Evaluation, and Treatment of High Blood Pressure. 1997. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med, 157:2413-46.
    • Joint National Committee on, Detection, Evaluation, and Treatment of High Blood Pressure. 1997. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med, 157:2413-46.
  • 19
    • 2942635317 scopus 로고    scopus 로고
    • Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial
    • Julius S, Kjeldsen SE, Weber M, et al. 2004. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet, 363:2022-31.
    • (2004) Lancet , vol.363 , pp. 2022-2031
    • Julius, S.1    Kjeldsen, S.E.2    Weber, M.3
  • 20
    • 0035922447 scopus 로고    scopus 로고
    • Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    • Lewis EJ, Hunsicker LG, Clarke WR, et al. 2001. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med, 345:851-60.
    • (2001) N Engl J Med , vol.345 , pp. 851-860
    • Lewis, E.J.1    Hunsicker, L.G.2    Clarke, W.R.3
  • 21
    • 0027461577 scopus 로고
    • Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents
    • Materson BJ, Reda DJ, Cushman WC, et al. 1993. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med, 328:914-21.
    • (1993) N Engl J Med , vol.328 , pp. 914-921
    • Materson, B.J.1    Reda, D.J.2    Cushman, W.C.3
  • 22
    • 0030806211 scopus 로고    scopus 로고
    • The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population-based study in the elderly
    • Monane M, Bohn RL, Gurwitz JH, et al. 1997. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens, 10:697-704.
    • (1997) Am J Hypertens , vol.10 , pp. 697-704
    • Monane, M.1    Bohn, R.L.2    Gurwitz, J.H.3
  • 23
    • 0025805153 scopus 로고
    • Channeling bias in the interpretation of drug effects
    • Petri H, Urquhart J. 1991. Channeling bias in the interpretation of drug effects. Stat Med, 10:577-81.
    • (1991) Stat Med , vol.10 , pp. 577-581
    • Petri, H.1    Urquhart, J.2
  • 24
    • 0027445675 scopus 로고
    • Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives
    • Romano PS, Roos LL, Jollis JG. 1993. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol, 46:1075-97.
    • (1993) J Clin Epidemiol , vol.46 , pp. 1075-1097
    • Romano, P.S.1    Roos, L.L.2    Jollis, J.G.3
  • 25
    • 0038203004 scopus 로고    scopus 로고
    • Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March 2003
    • Staessen JA, Wang JG, Thijs L. 2003. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens, 21:1055-76.
    • (2003) J Hypertens , vol.21 , pp. 1055-1076
    • Staessen, J.A.1    Wang, J.G.2    Thijs, L.3
  • 26
    • 22144477948 scopus 로고    scopus 로고
    • Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: Results ofprospectively designed overviews of randomized trials
    • Turnbull F, Neal B, Algert C, et al. 2005. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results ofprospectively designed overviews of randomized trials. Arch Intern Med, 165:1410-19.
    • (2005) Arch Intern Med , vol.165 , pp. 1410-1419
    • Turnbull, F.1    Neal, B.2    Algert, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.